ACA has helped healthcare stocks boom

Amy Baxter | | Health Exec | Policy & Regulations

The Affordable Care Act has helped launch healthcare stocks into the stratosphere over the last eight years, contrary to what some critics of the healthcare law believed would happen.

In fact, healthcare companies have made out better in terms of their stock performance compared to the broader market, according to Axios.

Since the ACA became law, the S&P 500 healthcare index has jumped 168 percent, compared to the S&P 500’s increase of 141 percent and the Dow Jones’ gain of 139 percent, Axios reported. The S&P 500 healthcare index tracks the stock of 63 major healthcare companies, including health insurance providers such as Aetna, Cigna, Humana and more.

Some healthcare insurance providers are the net winners over the last several years, with the stock price of Medicaid and ACA insurer Centene jumping 1,100 percent. UnitedHealth Group has also seen its stock jump 700 percent.

See the full story below:

The ACA has helped, not hurt, the health care industry

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

To tell or not to tell: Do patients really need to know who—or what—writes their doctor’s notes?
CMS ends ACA special enrollment, changes deadline for signing up
Report: NIH continues to pull research grants, in violation of court orders
HHS sends 80K workers a $25K ‘voluntary’ resignation notice
More than 1,000 hospitals earn $700M opioid crisis judgment
VA planning 83,000 layoffs as part of restructuring

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.